GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » EV-to-EBIT

C21 Investments (XCNQ:CXXI) EV-to-EBIT : -2,727.21 (As of May. 26, 2024)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, C21 Investments's Enterprise Value is C$65.45 Mil. C21 Investments's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.02 Mil. Therefore, C21 Investments's EV-to-EBIT for today is -2,727.21.

The historical rank and industry rank for C21 Investments's EV-to-EBIT or its related term are showing as below:

XCNQ:CXXI' s EV-to-EBIT Range Over the Past 10 Years
Min: -3575.27   Med: -0.61   Max: 89.09
Current: -2727.21

During the past 13 years, the highest EV-to-EBIT of C21 Investments was 89.09. The lowest was -3575.27. And the median was -0.61.

XCNQ:CXXI's EV-to-EBIT is ranked worse than
100% of 672 companies
in the Drug Manufacturers industry
Industry Median: 16.985 vs XCNQ:CXXI: -2727.21

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. C21 Investments's Enterprise Value for the quarter that ended in Oct. 2023 was C$52.87 Mil. C21 Investments's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.02 Mil. C21 Investments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -0.05%.


C21 Investments EV-to-EBIT Historical Data

The historical data trend for C21 Investments's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments EV-to-EBIT Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.86 -3.07 47.42 3.84 8.75

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.43 8.75 12.91 33.52 -2,202.74

Competitive Comparison of C21 Investments's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where C21 Investments's EV-to-EBIT falls into.



C21 Investments EV-to-EBIT Calculation

C21 Investments's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=65.453/-0.024
=-2,727.21

C21 Investments's current Enterprise Value is C$65.45 Mil.
C21 Investments's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (XCNQ:CXXI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

C21 Investments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Oct. 2023 ) =EBIT / Enterprise Value (Q: Oct. 2023 )
=-0.024/52.8658
=-0.05 %

C21 Investments's Enterprise Value for the quarter that ended in Oct. 2023 was C$52.87 Mil.
C21 Investments's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of C21 Investments's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.
Executives
Bruce Macdonald Director

C21 Investments (XCNQ:CXXI) Headlines

No Headlines